Zobrazeno 1 - 10 of 200 pro vyhledávání: '"Patel, YT"'
1
Akademický článek
Ceftolozane/Tazobactam Probability of Target Attainment in Patients With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia.
Autor: Gao W; Merck & Co., Inc., Rahway, New Jersey, USA., Patel YT; Cognigen Corporation, Simulations Plus Company, Buffalo, New Jersey, USA., Zhang Z; Merck & Co., Inc., Rahway, New Jersey, USA., Johnson MG; Merck & Co., Inc., Rahway, New Jersey, USA., Fiedler-Kelly J; Cognigen Corporation, Simulations Plus Company, Buffalo, New Jersey, USA., Bruno CJ; Merck & Co., Inc., Rahway, New Jersey, USA., Rhee EG; Merck & Co., Inc., Rahway, New Jersey, USA., Anda C; Merck & Co., Inc., Rahway, New Jersey, USA., Feng HP; Merck & Co., Inc., Rahway, New Jersey, USA.
Publikováno v: Journal of clinical pharmacology [J Clin Pharmacol] 2023 Mar; Vol. 63 (3), pp. 352-357. Date of Electronic Publication: 2022 Nov 22.
Zobrazit plný text záznamu
2
Akademický článek
Evaluation of safety, pharmacokinetics, and pharmacodynamics of apixaban in pediatric subjects at risk of venous or arterial thrombotic disorder.
Autor: Merali SJ; Bristol Myers Squibb, Princeton, New Jersey, USA., Byon W; Pfizer, New York, New York, USA., Patel YT; Cognigen Corp, Buffalo, New York, USA., Elsrougy A; Bristol Myers Squibb, Princeton, New Jersey, USA., Marchisin D; Bristol Myers Squibb, Princeton, New Jersey, USA., Perera V; Bristol Myers Squibb, Princeton, New Jersey, USA., Chen W; Bristol Myers Squibb, Princeton, New Jersey, USA., He B; Bristol Myers Squibb, Princeton, New Jersey, USA., Murthy B; Bristol Myers Squibb, Princeton, New Jersey, USA.
Publikováno v: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2023 Apr; Vol. 12 (4), pp. 500-512. Date of Electronic Publication: 2023 Mar 05.
Zobrazit plný text záznamu
3
Akademický článek
Probability of Target Attainment Analyses to Inform Ceftolozane/Tazobactam Dosing Regimens for Patients With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia and End-Stage Renal Disease Receiving Intermittent Hemodialysis.
Autor: Feng HP; Merck & Co., Inc., Rahway, New Jersey, USA., Patel YT; Cognigen Corporation, a Simulations Plus Company, Buffalo, New York, USA., Zhang Z; Merck & Co., Inc., Rahway, New Jersey, USA., Fiedler-Kelly J; Cognigen Corporation, a Simulations Plus Company, Buffalo, New York, USA., Bruno CJ; Merck & Co., Inc., Rahway, New Jersey, USA., Rhee EG; Merck & Co., Inc., Rahway, New Jersey, USA., De Anda C; Merck & Co., Inc., Rahway, New Jersey, USA., Gao W; Merck & Co., Inc., Rahway, New Jersey, USA.
Publikováno v: Journal of clinical pharmacology [J Clin Pharmacol] 2023 Feb; Vol. 63 (2), pp. 166-171. Date of Electronic Publication: 2022 Oct 02.
Zobrazit plný text záznamu
4
Akademický článek
Population Pharmacokinetics of Selumetinib and Its Metabolite N-desmethyl-selumetinib in Adult Patients With Advanced Solid Tumors and Children With Low-Grade Gliomas.
Autor: Patel, YT1, Daryani, VM2, Patel, P3, Zhou, D4, Fangusaro, J5, Carlile, DJ6, Martin, PD7, Aarons, L3, Stewart, CF1 clinton.stewart@stjude.org
Publikováno v: CPT: Pharmacometrics & Systems Pharmacology. May2017, Vol. 6 Issue 5, p305-314. 10p.
Zobrazit plný text záznamu
6
Akademický článek
Exposure-Efficacy Analyses Support Optimal Dosing Regimens of Ceftolozane/Tazobactam in Participants with Hospital-Acquired/Ventilator-Associated Bacterial Pneumonia in ASPECT-NP.
Autor: Gao W; Merck & Co., Inc., Kenilworth, New Jersey, USA., Passarell J; Cognigen Corporation, a Simulations Plus Company, Buffalo, New York, USA., Patel YT; Cognigen Corporation, a Simulations Plus Company, Buffalo, New York, USA., Zhang Z; Merck & Co., Inc., Kenilworth, New Jersey, USA., Lin G; Merck & Co., Inc., Kenilworth, New Jersey, USA., Fiedler-Kelly J; Cognigen Corporation, a Simulations Plus Company, Buffalo, New York, USA., Bruno CJ; Merck & Co., Inc., Kenilworth, New Jersey, USA., Rhee EG; Merck & Co., Inc., Kenilworth, New Jersey, USA., De Anda CS; Merck & Co., Inc., Kenilworth, New Jersey, USA., Feng HP; Merck & Co., Inc., Kenilworth, New Jersey, USA.
Publikováno v: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2022 May 17; Vol. 66 (5), pp. e0139921. Date of Electronic Publication: 2022 Apr 26.
Zobrazit plný text záznamu
7
Akademický článek
A sensitive liquid chromatography tandem mass spectrometric method development and validation for ribociclib and its formulation.
Autor: Ramesh, J.1, Babu, B.1 babu@jssuni.edu.in, Sangamithra, R.1, Jothi, D. Anandha1, Meyyanathan, S. N.1, Gowramma, B.2
Publikováno v: Journal of Applied Pharmaceutical Science. Nov2024, Vol. 14 Issue 11, p227-232. 6p.
Zobrazit plný text záznamu
8
Akademický článek
Severe Pain after Endodontic Surgery: An Analysis of Incidence and Risk Factors.
Autor: Malagise CJ; Department of Endodontics, Texas A&M University College of Dentistry, Dallas, Texas., Khalighinejad N; North Dallas Endodontics, Dallas, Texas., Patel YT; North Dallas Endodontics, Dallas, Texas., Jalali P; Department of Endodontics, Texas A&M University College of Dentistry, Dallas, Texas., He J; Department of Endodontics, Texas A&M University College of Dentistry, Dallas, Texas. Electronic address: hejianing@tamu.edu.
Publikováno v: Journal of endodontics [J Endod] 2021 Mar; Vol. 47 (3), pp. 409-414. Date of Electronic Publication: 2020 Dec 23.
Zobrazit plný text záznamu
9
Akademický článek
Population Pharmacokinetic Analysis for Plasma and Epithelial Lining Fluid Ceftolozane/Tazobactam Concentrations in Patients With Ventilated Nosocomial Pneumonia.
Autor: Zhang Z; Merck & Co. Inc., Kenilworth, New Jersey, USA., Patel YT; Cognigen Corporation, a Simulations Plus Company, Buffalo, New York, USA., Fiedler-Kelly J; Cognigen Corporation, a Simulations Plus Company, Buffalo, New York, USA., Feng HP; Merck & Co. Inc., Kenilworth, New Jersey, USA., Bruno CJ; Merck & Co. Inc., Kenilworth, New Jersey, USA., Gao W; Merck & Co. Inc., Kenilworth, New Jersey, USA.
Publikováno v: Journal of clinical pharmacology [J Clin Pharmacol] 2021 Feb; Vol. 61 (2), pp. 254-268. Date of Electronic Publication: 2020 Sep 18.
Zobrazit plný text záznamu
10
Akademický článek
Pharmacokinetic basis for dosing high-dose methotrexate in infants and young children with malignant brain tumours.
Autor: Panetta JC; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Roberts JK; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Huang J; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA., Lin T; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA., Daryani VM; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Harstead KE; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Patel YT; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Onar-Thomas A; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN, USA., Campagne O; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Ward DA; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA., Broniscer A; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA., Robinson G; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA., Gajjar A; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA., Stewart CF; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN, USA.
Publikováno v: British journal of clinical pharmacology [Br J Clin Pharmacol] 2020 Feb; Vol. 86 (2), pp. 362-371. Date of Electronic Publication: 2020 Jan 08.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje